ADGM · XBRL financial data
Adagio Medical Holdings financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (ADGM's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Revenue from contracts with customers | — | 0 |
| Cost of revenue | — | 684 |
| Research and development | — | 10,639 |
| Selling, general and administrative | — | 10,567 |
| Operating income (loss) | — | (21,890) |
| Interest income | — | 477 |
| Interest expense | — | 2,906 |
| Other income (expense) | — | 195 |
| Income tax expense (benefit) | 0 | 0 |
| Net income (loss) | — | (25,084) |
| Earnings per share, basic USD per share | — | (1.51) |
| Earnings per share, diluted USD per share | — | (1.51) |
| Weighted average shares, basic thousands of shares | — | 16,577 |
| Weighted average shares, diluted thousands of shares | — | 16,577 |
Balance sheet
CSVFiscal years (ADGM's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Cash and cash equivalents | 20,586 | 17,105 |
| Accounts receivable | 35 | — |
| Inventory | 2,566 | 1,672 |
| Total current assets | 25,349 | 20,082 |
| Property and equipment, net | 1,961 | 1,535 |
| Right-of-use asset | 188 | 697 |
| Goodwill | 13,967 | 13,967 |
| Total assets | 48,448 | 43,253 |
| Accounts payable | 2,840 | 1,082 |
| Accrued liabilities | 3,673 | 6,996 |
| Total current liabilities | 7,763 | 8,233 |
| Lease liability, non-current | 46 | 563 |
| Total liabilities | 28,536 | 30,851 |
| Accumulated deficit | (70,586) | (95,609) |
| Total stockholders' equity | 19,912 | 12,402 |
| Total liabilities and equity | 48,448 | 43,253 |
| Common shares outstanding (cover page) thousands of shares | 15,382 | 22,210 |
Cash flows
CSVFiscal years (ADGM's year ends in late December)
| In thousands of dollars | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|
| Net income (loss) | — | (25,084) |
| Stock-based compensation | — | 1,479 |
| Depreciation and amortization | — | 970 |
| Net cash from operating activities | — | (19,014) |
| Purchases of property and equipment | — | 374 |
| Net cash from investing activities | — | (374) |
| Proceeds from issuing common stock | — | 16,134 |
| Net cash from financing activities | — | 16,134 |
| Net change in cash | — | (3,481) |
Compare with peers
SIC 3841 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (3841) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Adagio Medical Holdings | 7,740 | 0 | (5,260)* | 22.2M | 1.5 quarters | 10-QJun 30, 2026 |
| Dynatronicsadded: same SIC | 762 | 7,024 | (93) | 16.0M | 8.2 quarters | 10-QSep 30, 2025 |
| Profusaadded: same SIC | 719 | not reported | (2,632)* | 605,647 | 0.3 quarters | 10-QJun 30, 2026 |
| Premier Air Charter Holdingsadded: same SIC | 157 | 5,784 | 318* | 280.8M | — | 10-QJun 30, 2026 |
| QHSLabadded: same SIC | 317 | 847 | (7.8)* | 15.0M | 40.6 quarters | 10-QJun 30, 2026 |
| Vycor Medicaladded: same SIC | 159 | 418 | (4.8)* | 33.4M | 32.8 quarters | 10-QJun 30, 2026 |
| INVO Fertilityadded: same SIC | 3,733 | 2,175 | (1,101)* | 2.5M | 3.4 quarters | 10-QJun 30, 2026 |
| Stimcell Energeticsadded: same SIC | 6.9 | not reported | (109) | 21.1M | 0.1 quarters | 10-QAug 31, 2026 |
| Bluejay Diagnosticsadded: same SIC | 9,599 | not reported | (1,499)* | 4.5M | 6.4 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.